Liquidia Corporation (LQDA)
Last updated: 2026-10-21 21:09:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Liquidia Corporation (LQDA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $38.83, with a market capitalization of $3.05B and a P/E ratio of 23.47. Over the past 52 weeks, its price has ranged from $21.94 to $93.61. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$3.05B | |
$36.65 | |
$93.61 | |
$2.25 | |
$36.35 | |
3.45M | |
3.18M | |
23.47 | |
$93.61 | |
$21.94 | |
-- | |
-- |
Liquidia Corporation (LQDA) After-Hours Stock Price
Liquidia Corporation (LQDA) is trading at $38.82 in after-hours trading as of 2026-10-21 21:06:00, up 6.80% ($2.47) from the regular-session close of $36.35.
After-hours trading shows how investors are pricing LQDA after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Liquidia Corporation (LQDA) 7-Day Stock Price Change
Over the past seven days, Liquidia Corporation (LQDA) moved from $27.67 to $38.83, representing a gain of 40.31% ($11.16).
The stock traded between $26.13 and $39.16 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 7.43 million shares, down versus the previous seven-day period, indicating lower trading activity.
LQDA 52-Week Price Position
Position in Range: 23.6%
LQDA is currently trading at $38.83, placing it 23.6% of the way from its 52-week low of $21.94 to its 52-week high of $93.61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Liquidia Corporation (LQDA)?
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Liquidia Corporation Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 216 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Liquidia Corporation (LQDA) Stock on MEXC
Eligible investors can buy real shares of Liquidia Corporation (LQDA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Liquidia Corporation (LQDA) stock price today?
2.Is LQDA stock going up or down today?
3.What is LQDA pre-market price?
4.What is LQDA after-hours price?
5.Is LQDA stock trading now?
6.Where does LQDA sit relative to its 52-week high and low?
7.What sector is Liquidia Corporation in?
8.What is Liquidia Corporation's market capitalization and where is it listed?
9.How is LQDA valued in terms of P/E ratio and EPS?
10.Does Liquidia Corporation pay a dividend?
Explore More US Stocks
Search Stocks
LQDA Stock Calculator
Estimate the value between LQDA shares and USD.
LQDA Shares to USD
1.00 LQDA shares = 38.825 USD
Calculations are estimates based on the latest available price and are for reference only.


